Skip to content

Cleanrooms

Compounding Pharmacy Facility Design: Non-Sterile, Sterile and Hazardous

How non-sterile, sterile and hazardous-drug compounding change the facility: room sequence, personnel and material flows, gowning, airlocks, primary engineering controls, HVAC, environmental monitoring, and why water needs depend on the project.

Published
Author
ALVEDA SOLUTIONS Engineering Team
Reading time
5 min

A compounding pharmacy prepares medicines for individual patients or for specific clinical needs, usually in small batches and often under time pressure. The facility is smaller than a manufacturing plant, but the engineering questions are the same: how is the product protected, how are people protected, and how does the room layout make the right behaviour the easy one?

The answer depends first on what is compounded. Non-sterile, sterile and hazardous-drug compounding place different demands on the building, and many pharmacies combine two or three of them under one roof.

The frameworks behind the design

Requirements for compounding come from the jurisdiction where the pharmacy operates. In the United States they are set out mainly in the USP general chapters on non-sterile compounding, sterile compounding and hazardous drugs in healthcare settings, enforced by state boards and other authorities. Many other countries refer to the PIC/S guide on good preparation practices in healthcare establishments, to national pharmacy regulations, or to a combination. The design basis should name the frameworks that apply to the project and the edition in force, because classification, monitoring and room requirements are defined there and differ between them.

Non-sterile compounding

Non-sterile preparations such as oral liquids, creams, ointments and capsules do not need a classified cleanroom, but they do need a dedicated, controlled space. The design focuses on separation from dispensing and general pharmacy traffic, cleanable finishes, adequate storage for ingredients and components, temperature and humidity suited to the materials, and dust control where powders are weighed. Containment ventilated enclosures or similar local extraction are used where powder handling creates exposure.

Sterile compounding

Sterile compounding relies on two layers of control. The primary engineering control (PEC) — a laminar airflow workbench, biological safety cabinet, compounding aseptic isolator or similar device — provides the critical environment where the preparation is exposed. The secondary engineering control is the room around it: typically a buffer room where the PEC sits, entered through an ante-room where hand hygiene and garbing take place.

The applicable framework defines the air classification of the PEC, the buffer room and the ante-room, and how they are tested. Engineering then turns that into a room sequence that works: the ante-room is arranged so that a person moves from a less clean to a cleaner side, the hand-wash position and the garbing bench are placed where they do not create cross-traffic, and materials enter through a pass-through or a defined wipe-down step instead of being carried in with the operator. Some frameworks also allow a smaller segregated compounding area for limited, lower-risk activity, with conditions on what can be prepared there.

Hazardous-drug compounding

When hazardous drugs such as many antineoplastics are compounded, protecting staff and the surrounding areas becomes a design driver alongside protecting the product. That changes several decisions at once:

  • The containment PEC, such as a suitable biological safety cabinet or containment isolator, is typically exhausted to the outside rather than back into the room.
  • The room in which hazardous drugs are compounded is normally held at negative pressure relative to its surroundings, which means the airlock and ante-room arrangement has to protect cleanliness and containment at the same time.
  • Receipt, unpacking and storage of hazardous drugs are planned as part of the containment chain, not left to general stores.
  • Personal protective equipment is put on and taken off at defined points, with waste and spill provisions placed along the exit route.
  • Hazardous and non-hazardous sterile compounding are kept in separate rooms unless the applicable framework allows otherwise.

Flows, gowning and airlocks

In a compounding suite, most contamination risk arrives with people and materials. A flow diagram drawn before the room layout is fixed shows where personnel enter and leave, how ingredients and components move from receipt to the PEC, how finished preparations leave for checking and dispensing, and how waste, including hazardous waste, leaves the suite. Crossing routes are resolved on that diagram, not on site.

Airlocks and ante-rooms are where the cleanliness and pressure strategy is either upheld or lost. Their size has to suit the garbing sequence and the number of people who use them at shift change; door swings, interlocks and visual indication of pressure all affect how well they work in daily use.

HVAC for compounding suites

The HVAC system delivers the air classification, the pressure relationships, temperature and humidity that staff and products need, and the exhaust for containment devices. Typical design questions include whether the suite can share an air handling unit with other areas, where HEPA filtration is placed, how much air must be supplied to support the classification and to dilute and remove particles, how the exhaust of containment PECs is balanced when a cabinet is switched on or off, and what happens to room pressures on loss of power or fan failure. Required air change rates and pressure differences come from the applicable framework and the project’s risk assessment, and they are verified during certification.

Environmental monitoring and certification

Sterile compounding areas are certified and monitored according to the applicable framework: airborne particle counts, viable air and surface sampling, differential pressure, and temperature and humidity. Design affects how practical that is. Pressure sensors and displays need agreed locations; sampling points must be reachable without disturbing work; data logging and alarms must be able to show what happened overnight and at weekends. These decisions are cheaper to make on drawings than after the ceiling is closed.

Water needs are project-dependent

A compounding pharmacy does not automatically need a pharmaceutical water generation plant. Many sterile preparations use commercially supplied sterile water or diluents, and non-sterile preparations may use purchased purified water in line with the formulation requirements. Where a project does call for on-site water treatment, its grade, capacity and monitoring are defined from the formulary and the applicable framework. Hand-wash sinks still need careful placement, because the applicable frameworks set conditions on where sinks and drains may sit relative to classified areas.

Key points

  • Identify the compounding types and the applicable framework before drawing rooms.
  • Draw personnel, material, preparation and waste flows first, then fit the rooms to them.
  • Treat the PEC and the room around it as one system, including exhaust for containment devices.
  • Plan monitoring points, alarms and certification access during design.
  • Define water needs from the formulary instead of assuming a water plant.

This article is general technical information. It is not a substitute for the current text of the applicable regulations and guidance, or for a project-specific assessment.

Related articles and topics

All insights
  • 01Cleanrooms

    Cleanroom Pressure Cascades and Classification: How They Are Developed

    How cleanroom classification and pressure cascades relate, when a cascade protects the product and when it protects people, and why differential pressure setpoints are developed for each project from classification, process, risk, containment, door and airlock strategy rather than copied.

  • 02Pharma Engineering

    Pharmaceutical Water Systems: RO, PW and WFI Explained

    How a pharmaceutical water system is built up from pretreatment through reverse osmosis and polishing to Purified Water, where Water for Injection fits, and why the WFI technology, the loop temperature and the sanitization method are project decisions rather than fixed answers.

  • 03GMP

    EU GMP Annex 1 and the Contamination Control Strategy

    What a contamination control strategy (CCS) is under the revised EU GMP Annex 1, what it connects, and how facility design, HVAC, flows, cleaning, monitoring, sterilization, qualification and CAPA feed into one documented strategy.

Next step

Planning a pharmaceutical project?

Share the product type, the current stage and the main constraints. We will respond with a proposed scope and next steps.

+20 101 171 1700